Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2021

06.08.2020 | Case Report

An Uncommon Cause of Hematochezia

verfasst von: Rizwan Ishtiaq, Muhammad Aziz, Darlene M. Wilhelm, Vinaya V. Gaduputi, Syed Uzair Hamdani

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

A diagnosis of pancreatic cancer carries a very poor prognosis and is the fourth leading cause of cancer-related mortality in developed nations [1]. In the USA, pancreatic cancer accounts for almost 3% of all the cancers and almost 7% of all cancer deaths [2]. The poor prognosis associated with pancreatic cancer is directly related to the timing of diagnosis which frequently occurs when the cancer is already in an advanced stage with approximately 50% of the patients having metastasis at the time of diagnosis and only 20% having resectable tumors [3]. Common sites for metastasis of pancreatic cancer include the liver, peritoneum, lungs, and lymph nodes. Rarely, pancreatic cancer metastasizes to the colon [1]. This case report highlights an occurrence of pancreatic adenocarcinoma with metastasis to the colon that presented clinically as hematochezia. An extensive literature search found only nine cases of colonic metastasis from primary pancreatic cancer. We did not include cases which involved direct extension of the pancreatic lesion into the colonic mass or cancers involving pancreatobiliary systems in our review. Our case is unique in a sense that it is the second reported case in literature which initially presented with hematochezia and was ultimately found to be pancreatic cancer with metastasis to the colon. …
Literatur
1.
Zurück zum Zitat Kim W, Lee Y. Metachronous colonic metastasis from pancreatic cancer presenting as mechanical obstruction: a case report. Clin Imaging. 2015;39(4):699–701.CrossRef Kim W, Lee Y. Metachronous colonic metastasis from pancreatic cancer presenting as mechanical obstruction: a case report. Clin Imaging. 2015;39(4):699–701.CrossRef
2.
Zurück zum Zitat American Cancer Society. Facts & Figures 2019. American Cancer Society, Atlanta; 2019. American Cancer Society. Facts & Figures 2019. American Cancer Society, Atlanta; 2019.
3.
Zurück zum Zitat Huguet F, Mukherjee S, Javle M. Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy. Clin Oncol. 2014;26(9):560–8.CrossRef Huguet F, Mukherjee S, Javle M. Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy. Clin Oncol. 2014;26(9):560–8.CrossRef
4.
Zurück zum Zitat Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Case report metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Case report metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral
5.
Zurück zum Zitat Nogueira ST, Pinto BL, Silva EF, Garcia HA, Carneiro F. Pancreatic cancer presenting as colonic disease. A rare case report. Int J Surg Case Rep. 2018;44:4–7.CrossRef Nogueira ST, Pinto BL, Silva EF, Garcia HA, Carneiro F. Pancreatic cancer presenting as colonic disease. A rare case report. Int J Surg Case Rep. 2018;44:4–7.CrossRef
6.
Zurück zum Zitat Inada K, Shida D, Noda K, Inoue S, Warabi M, Umekita N. Metachronous colonic metastasis from pancreatic cancer seven years post-pancreatoduodenectomy. World J Gastroenterol: WJG. 2013;19(10):1665–8.CrossRef Inada K, Shida D, Noda K, Inoue S, Warabi M, Umekita N. Metachronous colonic metastasis from pancreatic cancer seven years post-pancreatoduodenectomy. World J Gastroenterol: WJG. 2013;19(10):1665–8.CrossRef
7.
Zurück zum Zitat Bellows C, Gage T, Stark M, McCarty C, Haque S. Metastatic pancreatic carcinoma presenting as colon carcinoma. South Med J. 2009;102(7):748–50.CrossRef Bellows C, Gage T, Stark M, McCarty C, Haque S. Metastatic pancreatic carcinoma presenting as colon carcinoma. South Med J. 2009;102(7):748–50.CrossRef
8.
Zurück zum Zitat Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral Nakaya T, Oshiro H, Saito T, Sakuma Y, Horie H, Sata N, et al. Metastasis of pancreatic cancer within primary colon cancer by overtaking the stromal microenvironment. Int J Clin Exp Pathol. 2018;11(6):3141–6.PubMedPubMedCentral
9.
Zurück zum Zitat Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):1–5.CrossRef Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):1–5.CrossRef
10.
Zurück zum Zitat Gizzi G, Santini D, Golfieri R, Fuccio L. Diffuse colonic metastases from primary pancreatic cancer. Gastrointest Endosc. 2017;85(3):678–9.CrossRef Gizzi G, Santini D, Golfieri R, Fuccio L. Diffuse colonic metastases from primary pancreatic cancer. Gastrointest Endosc. 2017;85(3):678–9.CrossRef
11.
Zurück zum Zitat Lee P, Sutherland D, Feller ER. Massive gastrointestinal bleeding as the initial manifestation of pancreatic carcinoma. Int J Pancreatol. 1994;15(3):223–7.PubMed Lee P, Sutherland D, Feller ER. Massive gastrointestinal bleeding as the initial manifestation of pancreatic carcinoma. Int J Pancreatol. 1994;15(3):223–7.PubMed
12.
Zurück zum Zitat Ogu US, Bloch R, Grace Park BAMS. A rare case of metachronous skip metastasis of pancreatic cancer to the colon. Am Surg. 2012;78(7):E342.CrossRef Ogu US, Bloch R, Grace Park BAMS. A rare case of metachronous skip metastasis of pancreatic cancer to the colon. Am Surg. 2012;78(7):E342.CrossRef
13.
Zurück zum Zitat Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):99.CrossRef Miyasaka M, Noji T, Tanaka K, Nakanishi Y, Asano T, Ebihara Y, et al. Oncological emergency surgery for metachronous large and small bowel metastases after pancreaticoduodenectomy for pancreatic cancer: a case report. Surg Case Rep. 2018;4(1):99.CrossRef
14.
Zurück zum Zitat Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system: International Agency for Research on Cancer; 2010. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system: International Agency for Research on Cancer; 2010.
15.
Zurück zum Zitat Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas: Elsevier Health Sciences; 2009. Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas: Elsevier Health Sciences; 2009.
16.
Zurück zum Zitat Yokota T, Kunii Y, Kagami M, Yamada Y, Takahashi M, Kikuchi S, et al. Metastatic breast carcinoma masquerading as primary colon cancer. Am J Gastroenterol. 2000;95(10):3014–6.CrossRef Yokota T, Kunii Y, Kagami M, Yamada Y, Takahashi M, Kikuchi S, et al. Metastatic breast carcinoma masquerading as primary colon cancer. Am J Gastroenterol. 2000;95(10):3014–6.CrossRef
17.
Zurück zum Zitat Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174(2):169–74.CrossRef Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, et al. New consensus nomenclature for mammalian keratins. J Cell Biol. 2006;174(2):169–74.CrossRef
18.
Zurück zum Zitat Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.CrossRef Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962–72.CrossRef
19.
Zurück zum Zitat Voravud N, El-Naggar AK, Balch CM, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992;15(4):365–9.CrossRef Voravud N, El-Naggar AK, Balch CM, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992;15(4):365–9.CrossRef
20.
Zurück zum Zitat Conroy T, Bachet JB, Ayav A, Huguet F, Lambert A, Caramella C, et al. Current standards and new innovative approaches for treatment of pancreatic cancer. Eur J Cancer. 2016;57:10–22.CrossRef Conroy T, Bachet JB, Ayav A, Huguet F, Lambert A, Caramella C, et al. Current standards and new innovative approaches for treatment of pancreatic cancer. Eur J Cancer. 2016;57:10–22.CrossRef
21.
Zurück zum Zitat Cascinu S, Falconi M, Valentini VI, Jelic S, ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl_5):v55–8.CrossRef Cascinu S, Falconi M, Valentini VI, Jelic S, ESMO Guidelines Working Group. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl_5):v55–8.CrossRef
Metadaten
Titel
An Uncommon Cause of Hematochezia
verfasst von
Rizwan Ishtiaq
Muhammad Aziz
Darlene M. Wilhelm
Vinaya V. Gaduputi
Syed Uzair Hamdani
Publikationsdatum
06.08.2020
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2021
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00470-4

Weitere Artikel der Ausgabe 1/2021

Journal of Gastrointestinal Cancer 1/2021 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.